Currently, there are 29.56M common shares owned by the public and among those 29.23M shares have been available to trade.
The company’s stock has a 5-day price change of -6.09% and 13.24% over the past three months. INSP shares are trading -11.61% year to date (YTD), with the 12-month market performance down to -24.30% lower. It has a 12-month low price of $123.00 and touched a high of $257.40 over the same period. INSP has an average intraday trading volume of 606.96K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.63%, 14.65%, and -0.51% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Inspire Medical Systems Inc (NYSE: INSP) shares accounts for 107.82% of the company’s 29.56M shares outstanding.
It has a market capitalization of $5.36B and a beta (3y monthly) value of 1.32. The stock’s trailing 12-month PE ratio is 989.65, while the earnings-per-share (ttm) stands at $0.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.01% over the week and 4.77% over the month.
Analysts forecast that Inspire Medical Systems Inc (INSP) will achieve an EPS of 0.09 for the current quarter, 0.66 for the next quarter and 1.4 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.01 while analysts give the company a high EPS estimate of 0.01. Comparatively, EPS for the current quarter was -0.29 a year ago. Earnings per share for the fiscal year are expected to increase by 203.56%, and 86.98% over the next financial year.
Looking at the support for the INSP, a number of firms have released research notes about the stock. BofA Securities stated their Neutral rating for the stock in a research note on May 08, 2024, with the firm’s price target at $265-$225. RBC Capital Mkts coverage for the Inspire Medical Systems Inc (INSP) stock in a research note released on April 19, 2024 offered a Outperform rating with a price target of $285. Morgan Stanley was of a view on March 19, 2024 that the stock is Overweight, while KeyBanc Capital Markets gave the stock Overweight rating on February 06, 2024, issuing a price target of $278. Jefferies on their part issued Buy rating on January 19, 2024.
